Q2 2024 Holdings
Filed 2024-08-14 | 68 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amgen Inc(AMGN) | COM | 031162100 | $179.7M | 575,000 | 5.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $172.0M | 400,000 | 5.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $149.1M | 1,852,784 | 4.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $141.2M | 4,000,000 | 4.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $139.4M | 3,700,000 | 4.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $134.0M | 2,000,000 | 4.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $130.0M | 4,500,000 | 3.9% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $122.4M | 10,900,000 | 3.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $121.5M | 500,000 | 3.6% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $107.4M | 4,800,000 | 3.2% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $105.3M | 1,537,922 | 3.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $95.9M | 2,500,000 | 2.9% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $95.3M | 2,000,000 | 2.8% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $87.0M | 12,721,460 | 2.6% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $85.2M | 4,061,401 | 2.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $84.4M | 3,500,000 | 2.5% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $83.3M | 3,991,500 | 2.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $76.1M | 2,883,736 | 2.3% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $70.6M | 3,490,506 | 2.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $64.2M | 5,972,257 | 1.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $60.6M | 7,370,000 | 1.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $57.8M | 4,000,000 | 1.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $55.3M | 4,179,763 | 1.6% |
| Geron Corp(GERN) | COM | 374163103 | $55.1M | 13,000,000 | 1.6% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $53.1M | 15,272,172 | 1.6% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $51.1M | 2,870,131 | 1.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $51.0M | 3,923,849 | 1.5% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $44.8M | 1,500,000 | 1.3% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $44.0M | 6,103,817 | 1.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $43.3M | 4,000,000 | 1.3% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $41.5M | 6,100,000 | 1.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $41.3M | 1,756,667 | 1.2% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $39.4M | 1,000,000 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $37.3M | 950,000 | 1.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $29.7M | 466,089 | 0.9% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $28.0M | 6,000,000 | 0.8% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $27.8M | 3,904,785 | 0.8% |
| Hillevax Inc | COM | 43157M102 | $26.5M | 1,832,652 | 0.8% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $26.1M | 770,645 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $25.8M | 1,359,745 | 0.8% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $22.2M | 17,875,498 | 0.7% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $21.2M | 2,250,000 | 0.6% |
| Alector Inc(ALEC) | COM | 014442107 | $21.0M | 4,631,998 | 0.6% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $18.4M | 2,294,011 | 0.5% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $18.3M | 5,572,607 | 0.5% |
| Inovio Pharmaceuticals Inc(INO) | COM SHS | 45773H409 | $16.7M | 2,066,720 | 0.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $16.1M | 389,546 | 0.5% |
| Cybin Inc(CYBNEUR) | COM | 23256X100 | $15.8M | 58,139,535 | 0.5% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $14.9M | 7,419,355 | 0.4% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $13.8M | 4,184,100 | 0.4% |